Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Archive
Search
MARKETSAnalysis
The Quiet Return of the Tech IPO
Six companies filed publicly in July. Bankers say the real test comes in September.
Caplight Raises $16 Million for Private-Market Data and Trading Tools
BlackRock and Fin Capital are backing infrastructure that helps investors price, analyze and transact in shares of private companies.
Riviera Partners Acquires Lateral Labs
The executive-search firm is adding an AI-focused recruiting team with startup customers.
SpaceX Completes Record $75 Billion Public Offering
The rocket and satellite company entered Nasdaq trading at a valuation above $1.7 trillion.
OpenAI Files Confidentially for a U.S. Initial Public Offering
The ChatGPT maker joined Anthropic in a high-stakes race to bring frontier AI companies to public markets.
NewLimit Raises $435 Million to Advance Cellular Reprogramming Medicines
The longevity biotechnology company plans to move its first liver program toward human testing while expanding its discovery platform.
Anthropic Confidentially Files for U.S. IPO
The Claude developer moved ahead of OpenAI as frontier AI companies prepare for public scrutiny.
Mercury Raises $200 Million at a $5.2 Billion Valuation
The business-banking technology company is growing alongside a new wave of AI startups while pursuing approval for a national bank.
Cerebras Shares Soar in $5.55 Billion Nasdaq Debut
The AI chipmaker nearly doubled its offering price as investors sought another route into compute infrastructure.
